Form 4: Praxis Precision Medicines CFO Sells Shares to Cover Tax Obligations

Praxis Precision Medicines' Chief Financial Officer, Timothy Edwin Kelly, sold 139 shares of common stock to cover tax obligations related to vesting restricted share units.

Summary

• Timothy Edwin Kelly, the Chief Financial Officer of Praxis Precision Medicines, Inc., sold 139 shares of common stock on January 7, 2025.
• The sale was executed at a price of $77.52 per share.
• This transaction was to cover tax withholding obligations related to the vesting of previously reported restricted share units.
• Following the transaction, Mr. Kelly directly owns 12,206 shares of Praxis Precision Medicines stock.

Sentiment

Score: 5

Explanation: This is a neutral event, a routine transaction for tax purposes, and not indicative of any positive or negative sentiment towards the company.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The sale of shares to cover tax obligations is a common occurrence among executives receiving equity compensation.
• Similar transactions are regularly reported by executives at comparable biotech companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Praxis Precision Medicines, insider trading, Form 4, stock sale, CFO, Timothy Edwin Kelly, tax withholding, restricted share units